1244665

Marc A. Bjurlin, D.O. — FEI 3030732629

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 22, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Chapel Hill, NC (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance